Compare SEVN & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEVN | MBOT |
|---|---|---|
| Founded | 1986 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.2M | 126.3M |
| IPO Year | N/A | N/A |
| Metric | SEVN | MBOT |
|---|---|---|
| Price | $9.33 | $2.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | ★ $13.50 | $8.75 |
| AVG Volume (30 Days) | 177.1K | ★ 3.0M |
| Earning Date | 10-27-2025 | 11-12-2025 |
| Dividend Yield | ★ 11.62% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.04 | N/A |
| Revenue | ★ $29,408,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2,166.67 |
| P/E Ratio | $9.30 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.30 | $0.93 |
| 52 Week High | $13.97 | $4.67 |
| Indicator | SEVN | MBOT |
|---|---|---|
| Relative Strength Index (RSI) | 56.76 | 46.82 |
| Support Level | $8.30 | $2.31 |
| Resistance Level | $9.81 | $2.55 |
| Average True Range (ATR) | 0.22 | 0.17 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 67.55 | 52.11 |
Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.
Microbot Medical Inc is a breakthrough medical device company. The group is focused on transforming endovascular procedures through advanced robotic technology. Microbot's LIBERTY Endovascular Robotic System is the first single-use, remotely operated robotic solution designed for precision, efficiency and provider safety. With a robust intellectual property portfolio and a deep commitment to innovation, Microbot is shaping the future of endovascular care.